Follicular unit transplantation for male-pattern hair loss: Evaluation of 120 patients

Baser, Nesrin Tan; Cigsar, Bulent; Akbuga, Unzile Balci; Terzioğlu, Ahmet; Aslan, Gürcan

doi:10.1016/j.bjps.2006.03.041

Cited by 16 publications

(7 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Follicular unit transplantation requires an adequate hair-bearing donor site and carries a 5 percent complication rate, including donor-site necrosis, hypertrophic scarring, keloids, and folliculitis. [11][12][13][14] Several studies have shown higher dihydrotestosterone and androgen receptor concentrations in the scalp of androgenic alopecia patients. 15,16 Although these molecular associations have been well defined, the specific causes leading to increased dihydrotestosterone or androgen receptor concentrations have not been well elucidated.…”

mentioning

confidence: 99%

The Contribution of Endogenous and Exogenous Factors to Male Alopecia

Gatherwright

Liu

Amirlak

et al. 2013

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

The Contribution of Endogenous and Exogenous Factors to Male Alopecia

Gatherwright

Liu

Amirlak

et al. 2013

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

“…[7][8][9][10] However, despite millions of dollars being spent on these therapies every year, 11 a definitive treatment has yet to be identified. A myriad of factors including genetic predisposition, age-related endocrine variations, and alterations of vascular supply can contribute to the putative efficacy of these interventions.…”

mentioning

confidence: 99%

Cessation of Hairline Recession following Open Forehead Rejuvenation

Guyuron

Kriegler²,

Davis³

et al. 2014

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

The purpose of this study was to investigate the efficacy of surgical deactivation of migraine headache trigger sites. Of 125 patients diagnosed with migraine headaches, 100 were randomly assigned to the treatment group and 25 served as controls, with 4:1 allocation. Patients in the treatment group were injected with botulinum toxin A for identification of trigger sites. Eighty-nine patients who noted improvement in their migraine headaches for 4 weeks underwent surgery. Eighty-two of the 89 patients (92 percent) in the treatment group who completed the study demonstrated at least 50 percent reduction in migraine headache frequency, duration, or intensity compared with the baseline data; 31 (35 percent) reported elimination and 51 (57 percent) experienced improvement over a mean follow-up period of 396 days. In comparison, three of 19 control patients (15.8 percent) recorded reduction in migraine headaches during the 1-year follow-up (p < 0.001), and no patients observed elimination. All variables for the treatment group improved significantly when compared with the baseline data and the control group, including the Migraine-Specific Questionnaire, the Migraine Disability Assessment score, and the Short Form-36 Health Survey. The mean annualized cost of migraine care for the treatment group (925 dollars) was reduced significantly compared with the baseline expense (7612 dollars) and the control group (5530 dollars) (p < 0.001). The mean monthly number of days lost from work for the treatment group (1.2) was reduced significantly compared with the baseline data (4.41) and the control group (4.4) (p = 0.003). The common adverse effects related to injection of botulinum toxin A included discomfort at the injection site in 27 patients after 227 injections (12 percent), temple hollowing in 19 of 82 patients (23 percent), neck weakness in 15 of 55 patients (27 percent), and eyelid ptosis in nine patients (10 percent). The common complications of surgical treatment were temporary dryness of the nose in 12 of 62 patients who underwent septum and turbinate surgery (19.4 percent), rhinorrhea in 11 (17.7 percent), intense scalp itching in seven of 80 patients who underwent forehead surgery (8.8 percent), and minor hair loss in five (6.3 percent). Surgical deactivation of migraine trigger sites can eliminate or significantly reduce migraine symptoms. Additional studies are necessary to clarify the mechanism of action and to determine the long-term results.

show abstract

“…This is the first method that was performed for hair transplantation and it is still commonly used; however, it has some limitations [24]. For example, during the procedure, magnification is required to diminish graft transection and obtain suitable grafts for implantation [25,26]. This increases the duration of graft preparation and decreases the graft count.…”

Section: Discussionmentioning

confidence: 97%

Follicular Unit Extraction Hair Transplantation with Micromotor: Eight Years Experience

2015

View full text Add to dashboard Cite

The main purpose of hair transplantation is to restore the hair loss. During the process, obtaining a natural appearance and adequate hair intensity is important. In the FUE method, grafts can be taken without changing their natural structure, there is no need for magnification, and the grafts can be transplanted directly without using any other processes. Because there is no suture in the FUE method, patients do not experience these incision site problems and scar formation. The FUE method enables us to achieve a natural appearance with less morbidity.

show abstract

Follicular unit transplantation for male-pattern hair loss: Evaluation of 120 patients

Cited by 16 publications

References 14 publications

The Contribution of Endogenous and Exogenous Factors to Male Alopecia

The Contribution of Endogenous and Exogenous Factors to Male Alopecia

Cessation of Hairline Recession following Open Forehead Rejuvenation

Follicular Unit Extraction Hair Transplantation with Micromotor: Eight Years Experience

Contact Info

Product

Resources

About